Medindia

X

NHS to fund Herceptin treatment for Stuart weaver

by Medindia Content Team on  May 9, 2006 at 2:15 PM Cancer News   - G J E 4
NHS to fund Herceptin treatment for Stuart weaver
Herceptin is one of a new generation drug that can treat breast cancer. But NHS said that it would fund the treatment for patients suffering from later stages of breast cancer. Due to this there are lots of legal challenges by cancer sufferers to force their local health care providers to pay for the drug. The latest being a British man, Stuart Weaver who filed the case and won it. He was told that his local NHS trust would fund for his treatment with Herceptin. Maidstone Weald Primary Care Trust said that they have agreed only after reviewing his age, clinical needs and advice from his medical consultants.
Advertisement

He is 37 years old and is suffering from breast cancer. Herceptin has created lot of commotion as it attacks only cancer cells and does not pose a lot of damage to the normal ones. It is also much better than the traditional chemotherapy. Herceptin is manufactured by Switzerland's Roche and is very expensive. It costs about $37,168 a year and is licensed only for patients suffering with advanced breast cancer. But doctors can prescribe it to those patients who they feel should receive the drug for treatment. Although it is shown that Herceptin can help patients in the early stages of breast cancer health authorities respond negatively for funding the treatment in early stage breast cancer except for exceptional cases.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: